“内养外护”新时代 医药企业转型升级大健康新思路

2017-05-26 佚名 华东宁波医药有限公司

面对快节奏、高压力的生活状态,人们对于健康生活理念的追求延伸出了保健食品、医药美妆、健康日化等品类,大健康产业应运而生。适逢“5·25全国护肤日”,以谐音“我爱我”提醒着人们关爱自己,而时尚之美与健康养护正是现代人关爱自我的新方式之一。日前,华东宁波医药有限公司(以下简称“华东宁波医药”)从消费者需求出发,提出“内养外护”的全面科学护养理念,正式宣布进军大健康领域。

面对快节奏、高压力的生活状态,人们对于健康生活理念的追求延伸出了保健食品、医药美妆、健康日化等品类,大健康产业应运而生。适逢“5·25全国护肤日”,以谐音“我爱我”提醒着人们关爱自己,而时尚之美与健康养护正是现代人关爱自我的新方式之一。日前,华东宁波医药有限公司(以下简称“华东宁波医药”)从消费者需求出发,提出“内养外护”的全面科学护养理念,正式宣布进军大健康领域。

理念创新 科技护养

目前中国的大健康产业仍处在发展的初期,产业细分及结构合理化仍需进一步提升和完善,我国传统医药生产和销售企业逐渐面临着经济转型的战略拐点。华东宁波医药作为老牌的生物医药企业,在继续夯实医药代理产品的基础上,将现行业务升级为医药事业部、医美事业部及健康美容事业部,顺势拓展大健康市场,以化妆品、功能性食品行业开启“内养外护”新的美容护肤时代。

2017年,刚刚组建的华东宁波医药健康美容事业部,一方面提出“内养外护、养护结合、内外兼修”的护肤新主张,另一方面,坚持科技创新成就美颜。在美国创立了产品研发实验室的基础上,在杭州又与浙江大学药学院建立透皮技术及护肤产品研究联合实验室,走产、学、研模式,以取得客观、真实的科学数据,确保研发产品的安全、有效!

内养外护 科学抗衰

当今世界正处于在知识与信息爆炸的年代,社会发展日新月异,工作节奏越来越快,加之国民普遍缺乏锻炼及食物不安全影响日益增多,致使人们普遍处于亚健康状态。有资料显示,90%以上的疾病发生与肠胃有关,膳食平衡是人体健康的重要因素,因此,从生命与健康的根本出发,采用全面、科学、有效的抗衰方法成为当今医学与大健康领域的研究课题。华东宁波医药推出赛缪斯首个健康品牌,正是基于内养外护、养护结合、内外兼修的护肤抗衰老理念。通过大量科学实验,他们推出一系列调养肠胃、清除重金属、改善睡眠的功能性食品,并与经典护肤用品有机组合,从而实现全面、科学的护肤抗衰老的功效。

为了严把产品质量关,华东宁波医药对赛缪斯品牌旗下所有产品进行严格检测,将重金属、激素、荧光剂、防腐剂等作为重点检测项目,并制定了严格的企业质量标准。

随着国务院发布《关于促进健康服务业发展的若干意见》,对健康产业给予了强有力的政策支持,医药企业进入产业升级的关键时刻。华东宁波医药以专业的科学研发团队、优秀的管理团队,把握时代机遇,以“内养外护”的科学养护理念,关注消费者健康需求,致力于成为大健康领域备受爱戴的国内知名企业。

SOURCE 华东宁波医药有限公司

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]
    2017-09-14 晓辰
  3. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]
    2017-05-28 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]
    2017-05-28 hyf030
  5. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1935718, encodeId=60011935e1862, content=<a href='/topic/show?id=cda0352e61c' target=_blank style='color:#2F92EE;'>#医药企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35276, encryptionId=cda0352e61c, topicName=医药企业)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sun Feb 04 12:31:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019303, encodeId=7d572019303bb, content=<a href='/topic/show?id=61f458359f7' target=_blank style='color:#2F92EE;'>#新思路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58359, encryptionId=61f458359f7, topicName=新思路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Thu Sep 14 04:31:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408926, encodeId=e8b9140892616, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456079, encodeId=c9ba14560e971, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515861, encodeId=c06a1515861d8, content=<a href='/topic/show?id=0c7543588e8' target=_blank style='color:#2F92EE;'>#大健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43588, encryptionId=0c7543588e8, topicName=大健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d10894444, createdName=ms1467340776200723, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582613, encodeId=90811582613ee, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 28 07:31:00 CST 2017, time=2017-05-28, status=1, ipAttribution=)]

相关资讯

养乐多倡导益生菌健康理念 科技让益生菌产业健康发展

由中国食品科学技术学会(CIFST)主办、养乐多(中国)投资有限公司等协办的“第十二届益生菌与健康国际研讨会”在内蒙古呼和浩特市成功举行。本届研讨会延续了往届科技与产业对接的优势,以“益生菌:技术及产业化”为主题,展示了业界最新科研成果,促进科技与产业界的交流与融合,积极推动益生菌产业健康发展。

英特尔与博德研究所携手加强基因组学研究解决方案

近日,英特尔联合博德研究所开发了“博德-英特尔基因组学堆栈 (BIGstack)”,英特尔以先进的分析流程参与和推动了基因组学研究。